Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06572098
Enrolling by invitation Not applicable

The Effect of Complex Decongestıve Therapy on Oxıdatıve Stress and Antıoxıdants

NCT06572098 · tracked via the Priya Life Science Turkey tracker
Sponsor
Baskent University
Phase
Not applicable
Started
2024-04-03
Last updated
2024-09-24

Condition(s) studied

What Are the Effects of Lymphedema Treatment

Investigational drug(s) / intervention(s)

Complex decongestive therapy

Complex decongestive therapy: Complex decongestive therapy consists of 4 phases. It will be performed by a lymphedema physiotherapist trained in Complex Decongestive Physiotherapy. Complex decongestive therapy consists of manual lymph drainage, skin care, multilayer bandaging and therapeutic exercises.

Study summary

It is aimed to determine the changes of complex decongestive therapy applications on oxidative stress parameters and antioxidants in patients with lymphedema after breast cancer treatment.

Eligibility

Sex
FEMALE
Min age
25 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Development of lymphedema after breast cancer treatment * Clinical stage of lymphedema Stage-2 or Stage-3 diagnosis Exclusion Criteria: * Receiving treatment for lymphedema in the last three months * Those diagnosed with severe heart failure and/or arrhythmia * Persistent infection in the affected extremities * Ongoing chemotherapy treatment * Diagnosed with liver disease

Primary outcome measure(s)

  • PON1 — will be assessed before treatment, immediately after treatment and one month after treatment.
    Paraoxonase

Trial sites (1)

FacilityCityRegionStatus
Baskent University Adana çukurova

More Baskent University trials in Turkey

Periodization-Based Strength Exercise Training in İndividuals With Type 2 Diabetes Recruiting
The Effect of Post-Scenario Debriefing and Rapid Cycle Deliberate Practice in Anaphylactic Shock Training on Nursing Students' Knowledge, Performance, Self-Confidence, and Satisfaction Active, not recruiting
The Effect of Music and Musical Mobile Interventions on Pain and Physiological Parameters Recruiting
Effectiveness of High Intensity Laser Therapy in Management of Lumbar Disc Herniation Starting soon
AI-SUPPORTED FLIPPED LEARNING IN BREAST SELF-EXAMINATION TRAINING Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06572098 on ClinicalTrials.gov ↗ ← All trials in Turkey